Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Cardiovascular Diseases × Geritol × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 2 Breast Neoplasms 2 Uterine Cervical Dysplasia 1 Triple Negative Breast Neoplasms 1 Osteoporosis 1 Neuralgia 1 Hematologic Neoplasms 1 Head and Neck Neoplasms 1 Cardiovascular Diseases 1 Breast Neoplasms, Male 1 Bone Diseases, Metabolic 1

Interventions

Fatty Acids, Omega-3 2 Vorinostat 1 Vitamin E 1 Tumor Necrosis Factor Inhibitors 1 Therapeutics 1 Sugars 1 Rosuvastatin Calcium 1 Omeprazole 1 Nutrition Assessment 1 Naproxen 1 Liraglutide 1 Geritol 1 Fish Oils 1 Febuxostat 1 Desvenlafaxine Succinate 1 Colchicine 1 Cholecalciferol 1 Chocolate 1 Bortezomib 1 Atorvastatin 1 Aspirin 1 Antirheumatic Agents 1 Allopurinol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02422745 2025-09-24

COSMOS

Brigham and Women's Hospital

Phase 4 Completed

21,442 enrolled 31 charts

Cardiovascular Diseases, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡